Acute renal failure after isolated CABG surgery: Six years of experience

Minerva Anestesiologica

Volumn 73, Issue 11, 2007, Pages 559-565

  Landoni, Giovanni ^a   Bove, T ^a   Crivellari, M ^a   Poli, D ^a   Fochi, O ^a   Marchetti, C ^a   Romano, A ^a   Marino, G ^a   Zangrillo, A ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Coronary artery bypass; Coronary artery diseases; Kidney failure, acute

Indexed keywords

ADRENALIN; CATECHOLAMINE; CREATININE; DIAZEPAM; DOPAMINE; ENOXIMONE; FENOLDOPAM; FENTANYL; HEPARIN; INOTROPIC AGENT; ISOFLURANE; LOOP DIURETIC AGENT; MANNITOL; MORPHINE; PANCURONIUM; PROPOFOL; PROTAMINE SULFATE; SCOPOLAMINE;

ACUTE KIDNEY FAILURE; ADULT; AGE; AGED; ANESTHESIA INDUCTION; ANTICOAGULATION; AORTA BALLOON; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONTINUOUS HEMOFILTRATION; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; CRYSTALLOID; EMERGENCY SURGERY; ENDOTRACHEAL INTUBATION; FEMALE; FORWARD HEART FAILURE; HEART EJECTION FRACTION; HEART VENTRICLE FAILURE; HUMAN; HYDRATION; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; OPERATION DURATION; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK FACTOR; VASCULAR ACCESS;

ADULT; AGED; CORONARY ARTERY BYPASS; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; RISK FACTORS; TREATMENT OUTCOME;

EID: 37249049868     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley JA. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998;104:343-8.
2. Bove T, Calabrò MG, Landoni G, Aletti G, Marino G, Crescenzi G et al. The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth 2004;18:442-5.
3. Thakar CV, Liangos O, Yared JP, Nelson DA, Hariachar S, Paganini EP. Predicting acute renal failure after cardiac surgery: validation and redefinition of a risk stratification algorithm. Hemodial Int 2003;7:143-7.
4. Bellomo R, Kellum JA, Ronco C. Definig and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Int Care Med 2007;33:409-13.
5. Zangrillo A, Gerli C, Landoni G, Sparicio D, Roberti A, Sottocorna O et al. Anesthesiological management and outcome of 100 "beating heart" coronary artery bypass grafting. Minerva Anestesiol 2006;72:827-39.
6. Zangrillo A, Romano A, Landoni G, Sparicio D, Redaelli C, Gulletta S et al. Postoperative complications after coronary artery bypass grafting surgery. A comparison between the off pump and the on pump techniques. Eur J Anaesthesiol 2004;21:745-7.
7. Landoni G, Marino G, Gerli C, Bellorti F, Bore T, Pappalardo F et al. Beatine-heart coronary artery bypass graft surgery at San Raffaele Hospital: four years of experience. J Cardiothorac Vasc Anesth 2002;16:691-4.
8. Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F et al. Preoperative Renal Risk Stratification. Circulation 1997;97:878-84.
9. Andersson LG, Ekroth R, Bratteby LE, Hallaghen S, Wesslen O. Acute renal failure after coronary surgery: a study of incidence and risk factors in 2009 consecutive patients. Thorac Cardiovascular Surg 1993;41:237-41.
10. Landoni G, Roberti A, Boroli F, D'Avolio S, De Luca M, Calabro MG et al. Mitral valve surgery and acute renal failure. Eur J Anaesthesiol 2007;24:100-1.
11. Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant 1999;14:1158-62.
12. Ostermann ME, Taube D, Morgan CJ, Evans TW. Acute renal failure following cardiopulmonary bypass: a changing picture. Intens Care Med 2000;26:565-71.
13. Urzua J, Troncoso S, Bugedo G, Canessa R, Munoz H, Lema G et al. Renal function and cardiopulmonary bypass: effect of perfusion pressure. J Cardiothorac Vasc Anesth 1992;6:299-303.
14. Cheng DC, Bainbridge D, Martin JE, Novick RJ. Evidence-Based Perioperative Clinical Outcomes Research Group. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology 2005;102:188-203.
15. Gamoso MG, Phillips-Bute B, Landolfo KP: Off-pump versus on-pump coronary artery bypass surgery and postoperative renal dysfunction. Anesth Analg 2000;91:1080-4.
16. Crescenzi G, Landoni G, Romano A, Boroli F, Giardina G, Bignami E et al. A propensity score analysis on the effect of eliminating cardiopulmonary bypass for coronary artery bypass grafting. Minerva Anestesiol 2007;73:135-41.
17. Cartier R: Current trends and technique in OPCAB surgery. J Card Surg 2003;18:32-46.
18. Ascione R, Lloyd CT, Underwood MJ, Gomes WJ, Angelini GD. On-pump versus off-pump coronary revascularization: evaluation of renal function. Ann Thorac Surg 1999;68:493-8.
19. Landoni G, Zangrillo A, Franco A, Aletti.G, Roberti A, Calabro MG et al. Long-term outcome of patients who require renal replacement therapy after cardiac surgery. Eur J Anaesthesiol 2006;23:17-22.
20. Doggrell S.A. The therapeutic potential of dopamine modulators on the cardiovascular and renal systems. Expert Opin Investig Drugs 2002;11:631-44.
21. McGinn T, Guyatt G, Cook R, Meade M. Diagnosis: measuring agreement beyond chance. In: Guyatt G, Rennie D, editors. Users' guide to the medical literature. A manual for evidence-based clinical practice. Chicago, IL, USA: AMA Press; 2002. p. 461-70.
22. Conger JD, Schultz MF, Miller F, Robinette JB. Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int 1994;46:318-23.
23. Molitoris BA, Sandoval R, Sutton TA. Endothelial injury and dysfunction in ischemic acute renal failure. Crit Care Med 2002;30:S235-40.
24. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005;142:510-24.
25. Cogliati A, Vellutini R, Nardini A, Urovi S, Hamdam M, Landoni G et al. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomised clinical study. J Cardiothorac Vasc Anesth 2007. In press.
26. Roasio A, Lobreglio R, Santin A, Landoni G, Verdecchia C. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery. J Cardiothorac Vasc Anesth 2007. In press.
27. Landoni G, Biondi-Zoccai GG, Tumlin JA, Bove T, De Luca M, Calabro MG et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis 2007;49:56-68.
28. Landoni G, Biondi-Zoccai GG, Marino G, Bove T, Fochi O, Maj G et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery. A meta-analysis. J Cardiothorac Vasc Anesth 2007. In press.
29. Bove T, Landoni G, Calabro MG, Aletti G, Marino G, Cerchierini E et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 2005; 111:3230-5.
30. Fisher UM, Tossios P, Mehlhorn U. Renal protection by radical scavenging in cardiac surgery patients. Curr Med Res Opin 2005;21:1161-4.
31. Haase M, Haase-Fielitz A, Bagshaw SM, Reade MC, Morgera S, Seevenayagam S et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 2007;35:1-8.
32. Burns KE, Chu MW, Novick RJ, Fox SA, Gallo K, Martin CM et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery. JAMA 2005;294:342-50.
33. Ristikankare A, Kuitunen T, Kuitunen A, Uotila L, Vento A, Suojaranta-Ylinen R et al. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth 2006;97:611-6.
34. El-Hamamsy I, Stevens LM, Carrier M, Pellerin M, Bouchard D, Demers P et al. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 2007;133:7-12.